recommends AVOIDING routine use of HRT in women who have had breast cancer

The Canadian Breast Cancer Initiative now recommends AVOIDING routine use of HRT in women who have had breast cancer.

This is due to concerns about whether hormone replacement therapy is safe in these women.

For postmenopausal women with a history of breast cancer, suggest alternatives to HRT.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote